Form4insider filings, from the source

SEC Form 4 · accession 0001140361-17-018828

HALOZYME THERAPEUTICS, INC. · HALO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Randal J Kirk
Director · 10% Owner
Period of report
May 4, 2017
Accepted (ET)
May 8, 2017 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001159036

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 4, 2017A14,135$0.00A3,552,388D
Common StockF2holding———3,056,601Iby R.J. Kirk DOT
Common StockF2holding———290,460Iby JPK 2012
Common StockF2holding———46,701Iby Kellie L. Banks LTT
Common StockF2holding———3,977,445Iby Kapital Joe
Common StockF2holding———354,654Iby JPK 2009
Common StockF2holding———354,653Iby MGK 2009
Common StockF2holding———2,235Iby ZSK 2009
Common StockF2holding———302,954Iby JPK 2008
Common StockF2holding———302,954Iby MGK 2008
Common StockF2holding———302,954Iby ZSK 2008
Common StockF2holding———11,317Iby Lotus Capital
Common StockF2holding———216,795Iby Staff 2001
Common StockF2holding———6,328,853Iby NRM V
Common StockF2holding———131,144Iby Sr Staff 2006
Common StockF2holding———65,572Iby Staff 2006
Common StockF2holding———21,858Iby Incentive 2006

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses